{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:18:45Z","timestamp":1793215125099,"version":"4.5.0"},"reference-count":47,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,12]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the potential long-term impacts of adult growth hormone deficiency (GHD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Observational, retrospective matched cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>UK Clinical Practice Research Datalink (CPRD) Aurum database of primary care records with linkage to deprivation, secondary care and mortality data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults registered with CPRD between 31\/03\/2002 and 29\/03\/2021. Individuals with GHD were exact matched up to 1:4 with unaffected controls on sex, age group (by decade) and general practice with propensity score matching on age, ethnicity and deprivation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Mortality, cardiovascular disease (CVD), osteoporosis, fractures, depression, time off work and unemployment were investigated using Cox proportional hazards modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1573 adults with GHD were matched to 6234 unaffected controls. Median follow-up was 5.2 years for cases (IQR 2.2, 10.6) and 5.1 years for controls (IQR 2.2, 10.3). Adult GHD was associated with an increased risk of premature mortality (adjusted HR (aHR) 1.61; 95% CI 1.27, 2.03), CVD (aHR 2.38; 95%\u2009CI 1.84 to 3.07) and osteoporosis (aHR 4.03; 95%\u2009CI 2.88 to 5.65), but there was no evidence for an increased risk of fractures. A higher rate of depression (aHR 1.72; 95%\u2009CI 1.23 to 2.40) and unemployment (aHR 2.06; 95%\u2009CI 1.56 to 2.71) was also seen in adults with GHD, although there was no evidence for increased time off work.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GHD in adults is associated with increased risk of premature mortality, CVD, osteoporosis, depression and socioeconomic challenges such as unemployment. Timely diagnosis, appropriate treatment and comprehensive support are critical to mitigating these adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108782","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:55:35Z","timestamp":1770389735000},"page":"e108782","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Potential impacts of adult growth hormone deficiency: a population-based study in England"],"prefix":"10.1136","volume":"16","author":[{"given":"Sherwin","family":"Criseno","sequence":"first","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6226-3671","authenticated-orcid":false,"given":"Emma","family":"Gayton","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Araghi","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noya","family":"Machtiger-Azoulay","sequence":"additional","affiliation":[{"name":"Pfizer, Inc, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Toogood","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026062610411269000_16.2.e108782.1","doi-asserted-by":"crossref","unstructured":"Ranke MB . Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency. Front Endocrinol (Lausanne) 2021;12. doi:10.3389\/fendo.2021.720419","DOI":"10.3389\/fendo.2021.720419"},{"key":"2026062610411269000_16.2.e108782.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.382"},{"key":"2026062610411269000_16.2.e108782.3","doi-asserted-by":"crossref","first-page":"101824","DOI":"10.1016\/j.beem.2023.101824","article-title":"Differences between bone health parameters in adults with acromegaly and growth hormone deficiency: A systematic review","volume":"37","author":"Freda","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026062610411269000_16.2.e108782.4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2013-3921","article-title":"Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis","volume":"99","author":"Barake","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062610411269000_16.2.e108782.5","unstructured":"Feldt-Rasmussen U , Klose M , et al . Adult growth hormone deficiency- clinical management. South Dartmouth (MA): Endotext, 2000."},{"key":"2026062610411269000_16.2.e108782.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.4.1195"},{"key":"2026062610411269000_16.2.e108782.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.671492.x"},{"key":"2026062610411269000_16.2.e108782.8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4008\/jcrpe.v1i1.7","article-title":"Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study","volume":"1","author":"Berbero\u011flu","year":"2008","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2026062610411269000_16.2.e108782.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16413-1"},{"key":"2026062610411269000_16.2.e108782.10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2265.2012.04516.x","article-title":"Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients","volume":"78","author":"Fernandez-Rodriguez","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026062610411269000_16.2.e108782.11","doi-asserted-by":"crossref","unstructured":"Gasco V , Cambria V , Bioletto F , et al . Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment. Front Endocrinol (Lausanne) 2021;12. doi:10.3389\/fendo.2021.634415","DOI":"10.3389\/fendo.2021.634415"},{"key":"2026062610411269000_16.2.e108782.12","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2011.1887"},{"key":"2026062610411269000_16.2.e108782.13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2017.02.001","article-title":"Classical and non-classical causes of GH deficiency in adults","volume":"31","author":"Tanriverdi","year":"2017","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026062610411269000_16.2.e108782.14","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0047"},{"key":"2026062610411269000_16.2.e108782.15","doi-asserted-by":"crossref","unstructured":"Hoffman AR , Mathison T , Andrews D , et al . Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients\u2019 Perspective. J Endocr Soc 2022;6. doi:10.1210\/jendso\/bvac077","DOI":"10.1210\/jendso\/bvac077"},{"key":"2026062610411269000_16.2.e108782.16","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2014-1814","article-title":"Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency","volume":"99","author":"Stochholm","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062610411269000_16.2.e108782.17","unstructured":"National Institute for Health and Care Excellence . Human growth hormone (somatropin) in adults with gowth hormone deficiency. technology appraisal guidance [TA64]. 2003. Available: https:\/\/www.nice.org.uk\/guidance\/ta64"},{"key":"2026062610411269000_16.2.e108782.18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/cen.12848","article-title":"Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency","volume":"83","author":"Berglund","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026062610411269000_16.2.e108782.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1215"},{"key":"2026062610411269000_16.2.e108782.20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/clinem\/dgac199","article-title":"Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients","volume":"107","author":"Johannsson","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062610411269000_16.2.e108782.21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1028"},{"key":"2026062610411269000_16.2.e108782.22","doi-asserted-by":"crossref","first-page":"101835","DOI":"10.1016\/j.beem.2023.101835","article-title":"Meta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates?","volume":"37","author":"van Bunderen","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026062610411269000_16.2.e108782.23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11154-020-09599-w","article-title":"Growth hormone deficiency and replacement therapy in adults: Impact on survival","volume":"22","author":"van Bunderen","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"2026062610411269000_16.2.e108782.24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1084"},{"key":"2026062610411269000_16.2.e108782.25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11102-025-01500-9","article-title":"Prevalence and risk of complications in untreated patients with adult growth hormone deficiency","volume":"28","author":"Fukuoka","year":"2025","journal-title":"Pituitary"},{"key":"2026062610411269000_16.2.e108782.26","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91812-O"},{"key":"2026062610411269000_16.2.e108782.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04137.x"},{"key":"2026062610411269000_16.2.e108782.28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030840"},{"key":"2026062610411269000_16.2.e108782.29","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.2.398"},{"key":"2026062610411269000_16.2.e108782.30","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz034"},{"key":"2026062610411269000_16.2.e108782.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12963-023-00302-0"},{"key":"2026062610411269000_16.2.e108782.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0442-4"},{"key":"2026062610411269000_16.2.e108782.33","unstructured":"Momentum Data Ltd . Growth hormone deficiency impacts codelists. Available: https:\/\/github.com\/MomentumData\/Growth-Hormone-Deficiency-Impacts [Accessed 20 Oct 2025]."},{"key":"2026062610411269000_16.2.e108782.34","unstructured":"Department for Communities and Local Government . The english indices of deprivation. 2015. Available: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015 [Accessed 1 Oct 2022]."},{"key":"2026062610411269000_16.2.e108782.35","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-016-0274-7"},{"key":"2026062610411269000_16.2.e108782.36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719"},{"key":"2026062610411269000_16.2.e108782.37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2265.1994.tb02583.x","article-title":"The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism","volume":"41","author":"Toogood","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026062610411269000_16.2.e108782.38","unstructured":"Adrenal insufficiency: identification and management. NICE Guideline; 2024. Available: www.nice.org.uk\/guidance\/ng243"},{"key":"2026062610411269000_16.2.e108782.39","doi-asserted-by":"crossref","unstructured":"Sharma A , Lazarus K , Papadopoulou D , et al . Optimising prednisolone or prednisone replacement in adrenal insufficiency. Endocr Connect 2023;12. doi:10.1530\/EC-23-0097","DOI":"10.1530\/EC-23-0097"},{"key":"2026062610411269000_16.2.e108782.40","doi-asserted-by":"crossref","unstructured":"Benchimol EI , Smeeth L , Guttmann A , et al . The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015;12. doi:10.1371\/journal.pmed.1001885","DOI":"10.1371\/journal.pmed.1001885"},{"key":"2026062610411269000_16.2.e108782.41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3787"},{"key":"2026062610411269000_16.2.e108782.42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/07853890109002097","article-title":"Hypopituitarism and atherosclerosis","volume":"33","author":"Elhadd","year":"2001","journal-title":"Ann Med"},{"key":"2026062610411269000_16.2.e108782.43","first-page":"85","article-title":"Replacement therapy and cardiovascular diseases","volume":"31","author":"Boschetti","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"2026062610411269000_16.2.e108782.44","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12493"},{"key":"2026062610411269000_16.2.e108782.45","doi-asserted-by":"crossref","unstructured":"Deijen JB , Arwert LI , Witlox J , et al . Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis. Health Qual Life Outcomes 2005;3. doi:10.1186\/1477-7525-3-63","DOI":"10.1186\/1477-7525-3-63"},{"key":"2026062610411269000_16.2.e108782.46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01799.x"},{"key":"2026062610411269000_16.2.e108782.47","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s11102-024-01448-2","article-title":"Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis","volume":"27","author":"Slagboom","year":"2024","journal-title":"Pituitary"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:43:23Z","timestamp":1782495803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,6]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-108782"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108782","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}